Gerresheimer reports solid financial results in 2024 with revenue up 2.9% and adjusted EBITDA up 4.1%. Strategies for growth include expansions and focus on biologics solutions. Bormioli Pharma integr ...
Hosted on MSN4hOpinion
Europe is imploding. Blame liberals for German elections, not Nazi terrorThe far-right AfD becoming the second-largest formation in Germany's Reichstag raises serious questions about the growing ...
Germany could approve a fund to boost defence spending before the outgoing parliament steps down next month, while leaving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback